BioXcel Therapeutics
BTAI
#9513
Rank
HK$0.20 B
Marketcap
HK$5.13
Share price
2.37%
Change (1 day)
-86.31%
Change (1 year)

EPS for BioXcel Therapeutics (BTAI)

EPS in 2023 (TTM): -HK$55.72

According to BioXcel Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$55.25. In 2022 the company made an earnings per share (EPS) of -HK$45.93 a decrease over its 2021 EPS that were of -HK$31.71.

EPS history for BioXcel Therapeutics from 2017 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$55.7221.32%
2022-HK$45.9344.85%
2021-HK$31.717.65%
2020-HK$29.4587.62%
2019-HK$15.7051.88%
2018-HK$10.34350.92%
2017-HK$2.29

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$16.94-69.34%๐Ÿ‡บ๐Ÿ‡ธ USA